AIR AAR Corp posts Q1 2026 EPS beat shares rise 443 percent on favorable investor sentiment LOAN Manhattan Q1 2026 EPS narrowly misses estimates shares edge higher on neutral investor sentiment What Amplitech AMPGR does better than 90 of companies Soars 20260508 SMFG Sumitomo notches 164 percent Q1 2026 EPS beat shares rise 05 percent in todays session Ocugen Inc OCGN Q1 2026 Earnings Wider Loss Misses Estimate as PreRevenue Biotech Focuses on Pipeline Altimmune Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Development FCNCN Q1 2026 Earnings Strong EPS Beat Driven by Higher Net Interest Income CRVO Q1 2026 Earnings EPS Miss Reflects Continued Clinical Investment FANG Q1 2026 Earnings EPS Beats by 255 as Strong Operations Deliver Yet Shares Slip Greenfire Resources GFR Edges Higher Testing Key Resistance at 632 Anixa Biosciences ANIX Holds Steady at 273 as Consolidation Continues Allogene Therapeutics Edges Higher Testing Key Resistance at 21 Acumen Pharmaceuticals ABOS Edges Higher Amid Low Volume Tests Key Resistance Levels WFC Q1 2026 Earnings Narrow EPS Beat Fails to Inspire Markets